FDA Completes Inspection Of J&J Vaccine Maker Emergent BioSolutions, Cites Concerns Over Cross-Contamination, SanitationThe U.S. Food and Drug Administration has completed its inspection of the Baltimore-based Johnson & Johnson vaccine maker Emergent BioSolutions Tuesday and "cited a number of observations concerning whether the facility’s processes met our requirements and standards."
Johnson & Johnson COVID Vaccine Maker Emergent BioSolutions Asked To Stop Making Doses While FDA Investigation UnderwayEmergent BioSolutions, the Baltimore, Maryland-based company manufacturing the Johnson & Johnson coronavirus vaccines, was asked to stop manufacturing COVID-19 related products, while the Food & Drug Administration continues its investigation into quality control issues at the plant that ruined 15 million potential doses of the vaccine.
Baltimore City Health Officials Say They Will Switch To Moderna Doses While Johnson & Johnson On PauseBaltimore City will be pause doses of Johnson & Johnson until further notice following guidance from state health officials, the CDC and the FDA.
Amid Calls For Transparency, Emergent CEO Says Workers Did Not Accidentally Mix Johnson & Johnson, AstraZeneca VaccinesRobert Kramer, the CEO of Emergent BioSolutions, said in an interview with CNBC that he wanted to clear up “misunderstandings and misconceptions” about what happened at the company’s Baltimore facility last month when millions of Johnson & Johnson vaccine doses were reportedly ruined.